サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1414639

治療薬モニタリングの世界市場レポート 2024年

Therapeutic Drug Monitoring Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
治療薬モニタリングの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

治療薬モニタリングの市場規模は近年力強く成長しています。2023年の21億米ドルから2024年には22億9,000万米ドルへと、CAGR9.2％で拡大します。過去数年間に見られた成長は、慢性疾患の有病率の増加、医薬品の安全性に関する懸念、薬理ゲノミクスの統合、医薬品開発活動の活発化、精密医療に対する規制の重点化などに起因しています。

治療薬モニタリング市場規模は、今後数年で急成長が見込まれます。2028年の年間平均成長率（CAGR）は10.1％で、33億6,000万米ドルに成長します。予測期間中に予想される成長は、がん領域でのアプリケーションの増加、個別化医療の急増、高齢化率の世界の上昇、ポイントオブケア検査の利用拡大、医薬品研究開発への支出の増加に起因しています。予測期間中に予想される主な動向には、個別化医療、技術の進歩、医薬品開発と利用の増加、ポイントオブケア検査（POCT）、バイオマーカーとアッセイ技術の出現が含まれます。

治療薬モニタリング市場の成長は、臓器移植手術の普及率の増加によって促進されると予想されます。臓器移植は、ドナーからレシピエントへの臓器の外科的移植を伴う。免疫抑制剤のTDMは、固形臓器移植を受ける患者の管理に有効であることが証明されています。TDMを最適化することで、臓器拒絶反応につながる可能性のある毒性療法や不十分な低用量療法を避けることができるかもしれないです。例えば、米国で臓器移植を管理する非営利団体であるUnited Network for Organ Sharingの2023年1月の記事によると、2022年の臓器移植件数は2021年と比較して3.7％増加し、合計42,887件でした。したがって、臓器移植手術の急増は治療薬モニタリング市場の促進要因となっています。

治療薬モニタリング市場の成長が期待される背景には、医薬品の消費量の増加もあります。人間や動物の疾病を診断、治療、予防するために医療目的で使用される物質である医薬品は、投与レジメンを最適化するために治療薬モニタリングの対象となります。これには、副作用を最小限に抑えつつ有効性を確保するために、血流中の薬物濃度を測定・調整することが含まれます。2023年6月に国連薬物犯罪事務所が発表したところによると、2021年の世界の薬物注射人口は1,320万人で、これまでの推計値から18％増加しました。さらに、2021年の世界の薬物使用者数は2億9600万人以上と推定され、過去10年間で23％増加しています。したがって、薬物消費の増加は治療薬モニタリング市場の主要な促進要因です。

北米は、2023年の治療薬モニタリング市場において最大の地域でした。アジア太平洋は、予測期間中、世界の治療薬モニタリング市場レポートにおいて最も急成長する地域となる見込みです。治療薬モニタリング市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の治療薬モニタリング市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 消耗品
  • 装置
  • 免疫測定分析装置
  • クロマトグラフィーと検出器
  • 世界の治療薬モニタリング市場、技術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 免疫学的検査
  • 化学発光免疫測定法
  • 比色免疫測定法
  • 蛍光免疫測定法
  • ラジオイムノアッセイ
  • その他のイムノアッセイ
  • クロマトグラフィー-Ms
  • LC-Ms
  • Gc-Ms
  • 世界の治療薬モニタリング市場、薬剤クラス別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 抗てんかん薬
  • 抗生物質
  • 免疫抑制薬
  • 抗不整脈薬
  • 気管支拡張薬
  • 向精神薬
  • その他
  • 世界の治療薬モニタリング市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院検査室
  • 商業および民間の研究所
  • その他

第7章 地域および国の分析

  • 世界の治療薬モニタリング市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の治療薬モニタリング市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 治療薬モニタリング市場の競合情勢
  • 治療薬モニタリング市場の企業プロファイル
    • Abbott Laboratories Inc.
    • F. Hoffmann-La Roche AG
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
    • Sekisui Medical Co.

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

目次
Product Code: r12149

“Therapeutic Drug Monitoring Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on therapeutic drug monitoring market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for therapeutic drug monitoring? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The therapeutic drug monitoring market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product: Consumables; Equipment; Immunoassay Analyzers; Chromatography And Detectors
  • 2) By Technology: Immunoassays; Chemiluminescence Immunoassays; Chemiluminescence Immunoassays; Colorimetric Immunoassays; Fluorescence Immunoassays; Radioimmunoassay; Other Immunoassays; Chromatography-Ms; Lc-Ms; Gc-Ms
  • 3) By Class Of Drug: Antiepileptic Drugs; Antibiotic Drugs; Immunosuppressant Drugs; Antiarrhythmic Drugs; Bronchodilator Drugs; Psychoactive Drugs; Other Drugs
  • 4) By End-user: Hospital Laboratories; Commercial and Private Laboratories; Other End Users
  • Companies Mentioned: Abbott Laboratories Inc.; F. Hoffmann-La Roche AG; Siemens Healthineers AG; Thermo Fisher Scientific Inc.; Sekisui Medical Co.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Therapeutic drug monitoring (TDM) is a clinical procedure that involves continuous monitoring of a patient's bloodstream to assess the concentration of a specific medicine, ensuring the effectiveness of their dose regimens. TDM is employed for pharmaceuticals that have challenging target concentrations to monitor, medications exhibiting significant pharmacokinetic variability, drugs with established therapeutic effects and notable side effects, and medications with narrow therapeutic ranges.

The primary product types within therapeutic drug monitoring encompass consumables, equipment, immunoassay analyzers, chromatography, and detectors. Consumables for therapeutic drug monitoring include reagents and supplies utilized alongside TDM assays. Various technologies are employed, such as immunoassays, chemiluminescence immunoassays, colorimetric immunoassays, fluorescence immunoassays, radioimmunoassay, other immunoassays, chromatography-ms, lc-ms, and gc-mc. These technologies cover different drug classes, including antiseptic drugs, antibiotic drugs, immunosuppressant drugs, antiarrhythmic drugs, bronchodilator drugs, psychoactive drugs, and other drugs. Therapeutic drug monitoring is applicable in diverse settings, including hospital laboratories, commercial and private laboratories, and other end-users.

The therapeutic drug monitoring market research report is one of a series of new reports from The Business Research Company that provides therapeutic drug monitoring optical components market statistics, including therapeutic drug monitoring optical components industry global market size, regional shares, competitors with a therapeutic drug monitoring optical components market share, detailed therapeutic drug monitoring optical components market segments, market trends and opportunities, and any further data you may need to thrive in the therapeutic drug monitoring optical components industry. This therapeutic drug monitoring optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The therapeutic drug monitoring market size has grown strongly in recent years. It will grow from $2.1 billion in 2023 to $2.29 billion in 2024 at a compound annual growth rate (CAGR) of 9.2%. The growth observed in the historical period can be ascribed to an increasing prevalence of chronic diseases, concerns related to drug safety, integration of pharmacogenomics, a rise in drug development activities, and regulatory emphasis on precision medicine.

The therapeutic drug monitoring market size is expected to see rapid growth in the next few years. It will grow to $3.36 billion in 2028 at a compound annual growth rate (CAGR) of 10.1%. The anticipated growth in the forecast period can be attributed to the increasing applications in oncology, the surge in personalized medicine practices, the global rise in the aging population, the expanded use of point-of-care testing, and the growing expenditure on pharmaceutical research and development. Major trends expected in the forecast period encompass personalized medicine, technological advancements, increased drug development and utilization, point-of-care testing (POCT), and the emergence of biomarkers and assay technologies.

The growth of the therapeutic drug monitoring market is expected to be propelled by the increasing prevalence of organ transplant surgeries. Organ transplantation involves the surgical transfer of an organ from a donor to a recipient. Therapeutic drug monitoring (TDM) of immunosuppressive medications has proven effective in managing patients undergoing solid organ transplantation. Optimizing TDM may help avoid toxic or insufficiently low-dose therapy, which could lead to organ rejection. For example, a January 2023 article from the United Network for Organ Sharing, a non-profit organization managing organ transplants in the US, reported a 3.7% increase in organ transplants in 2022 compared to 2021, totaling 42,887 procedures. Hence, the surge in organ transplant surgeries is a driving factor for the therapeutic drug monitoring market.

The anticipated growth of the therapeutic drug monitoring market is also attributed to the increasing consumption of drugs. Drugs, substances used for medical purposes to diagnose, treat, or prevent diseases in humans or animals, are subject to therapeutic drug monitoring to optimize dosage regimens. This involves measuring and adjusting drug concentrations in the bloodstream to ensure efficacy while minimizing side effects. According to the United Nations Office on Drugs and Crime in June 2023, the global estimate of people who inject drugs was 13.2 million in 2021, marking an 18% increase from previous estimates. Additionally, the global drug usage estimate was over 296 million people in 2021, showing a 23% increase over the previous decade. Therefore, the rising consumption of drugs is a key driver for the therapeutic drug monitoring market.

Product innovations represent a prominent trend gaining traction in the therapeutic drug monitoring market. Leading companies within this sector are dedicated to creating novel products to cater to customer needs and fortify their positions in the market. In October 2021, Promise Proteomics, a proteomics company based in France, introduced mAbXmise kits-a proprietary solution that integrates labeled monoclonal antibodies, reagents, and laboratory supplies for quantifying therapeutic monoclonal antibodies through mass spectrometry. This multiplexing technique surpasses previous analytical methods, offering scientific, clinical, and economic perspectives that thoroughly meet the demands of routine therapeutic drug monitoring.

Prominent companies in the therapeutic drug monitoring market are directing their efforts toward developing testing solutions, including Point-of-Care Testing (POCT) solutions, to address the need for prompt decision-making. Point-of-Care Testing (POCT) involves a medical diagnostic approach that enables rapid testing and analysis of patient samples. For example, in May 2022, THERADIAG, a French company specializing in biological diagnostic tools, unveiled ez-Track1, a Point-of-Care Testing (POCT) solution tailored for therapeutic drug monitoring. This addresses the escalating demand for patient-centric diagnostics in the global healthcare sector. Initially launched in Europe, ez-Track1 conducts tests with whole blood samples, yielding results within 10 minutes and facilitating swift decision-making in implementing biotherapies. The CE-marked system's initial menu includes tests for Infliximab, anti-Infliximab, Adalimumab, and anti-adalimumab, with plans to expand rapidly to cover a broader range of chronic inflammatory diseases and other conditions.

In February 2023, Sentinel Diagnostics, an Italian in vitro diagnostic company, completed the acquisition of Eureka S.r.l. for an undisclosed amount. This strategic move positions Sentinel Diagnostics to emerge as a significant producer and developer of IVD tests. The expanded capabilities resulting from this acquisition will empower Sentinel Diagnostics to offer clinical laboratories a broader selection of assays, spanning from high-throughput core lab tests to the most cutting-edge, specialized second-level assays. EUREKA S.r.l. is an Italian IVD chromatographic company providing ready-to-use diagnostic kits for HPLC, GC, GC-MS, and LC-MS/MS applications, serving special clinical chemistry, therapeutic drug monitoring, occupational toxicology, and forensic toxicology purposes.

Major companies operating in the therapeutic drug monitoring market report are Abbott Laboratories Inc., F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Sekisui Medical Co., Buehlmann Laboratories AG, Danaher Corporation, Bio-Rad Laboratories Inc., bioMerieux SA, Randox Laboratories Limited, Chromsystems Instruments & Chemicals GmbH, Grifols SA, Merck KGaA, OraSure Technologies Inc., BioChem Pharmaceuticals, Beckman Coulter Inc., BioTelemetry Inc., DiaSorin S.p.A., Hologic Inc., Immunodiagnostic Systems Holdings plc, Kronus Inc., QuidelOrtho Corporation, Sysmex Corporation, TDM Solutions Inc., Theradiag, Tosoh Bioscience LLC, Trinity Biotech plc, Associated Regional and University Pathologists Inc., Mayo Clinic Laboratories, Quest Diagnostics

North America was the largest region in the therapeutic drug monitoring market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global therapeutic drug monitoring market report during the forecast period. The regions covered in the therapeutic drug monitoring market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the therapeutic drug monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The therapeutic drug monitoring market includes revenues earned by entities by providing drug monitoring, urine drug testing, drug efficacy testing, and drug toxicology. The market value includes the value of related goods sold by the service provider or included within the service offering. The therapeutic drug monitoring market also includes sales of Immunoassay kits, Mass spectrometry instruments, and Chromatography systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Therapeutic Drug Monitoring Market Characteristics

3. Therapeutic Drug Monitoring Market Trends And Strategies

4. Therapeutic Drug Monitoring Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Therapeutic Drug Monitoring Market Size and Growth

  • 5.1. Global Therapeutic Drug Monitoring Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Therapeutic Drug Monitoring Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Therapeutic Drug Monitoring Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Therapeutic Drug Monitoring Market Segmentation

  • 6.1. Global Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Consumables
  • Equipment
  • Immunoassay Analyzers
  • Chromatography And Detectors
  • 6.2. Global Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Immunoassays
  • Chemiluminescence Immunoassays
  • Colorimetric Immunoassays
  • Fluorescence Immunoassays
  • Radioimmunoassay
  • Other Immunoassays
  • Chromatography-Ms
  • Lc-Ms
  • Gc-Ms
  • 6.3. Global Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Antiepileptic Drugs
  • Antibiotic Drugs
  • Immunosuppressant Drugs
  • Antiarrhythmic Drugs
  • Bronchodilator Drugs
  • Psychoactive Drugs
  • Other Drugs
  • 6.4. Global Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Laboratories
  • Commercial and Private Laboratories
  • Other End Users

7. Therapeutic Drug Monitoring Market Regional And Country Analysis

  • 7.1. Global Therapeutic Drug Monitoring Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Therapeutic Drug Monitoring Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Therapeutic Drug Monitoring Market

  • 8.1. Asia-Pacific Therapeutic Drug Monitoring Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Therapeutic Drug Monitoring Market

  • 9.1. China Therapeutic Drug Monitoring Market Overview
  • 9.2. China Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Therapeutic Drug Monitoring Market

  • 10.1. India Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Therapeutic Drug Monitoring Market

  • 11.1. Japan Therapeutic Drug Monitoring Market Overview
  • 11.2. Japan Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Therapeutic Drug Monitoring Market

  • 12.1. Australia Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Therapeutic Drug Monitoring Market

  • 13.1. Indonesia Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Therapeutic Drug Monitoring Market

  • 14.1. South Korea Therapeutic Drug Monitoring Market Overview
  • 14.2. South Korea Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Therapeutic Drug Monitoring Market

  • 15.1. Western Europe Therapeutic Drug Monitoring Market Overview
  • 15.2. Western Europe Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Therapeutic Drug Monitoring Market

  • 16.1. UK Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Therapeutic Drug Monitoring Market

  • 17.1. Germany Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Therapeutic Drug Monitoring Market

  • 18.1. France Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Therapeutic Drug Monitoring Market

  • 19.1. Italy Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Therapeutic Drug Monitoring Market

  • 20.1. Spain Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Therapeutic Drug Monitoring Market

  • 21.1. Eastern Europe Therapeutic Drug Monitoring Market Overview
  • 21.2. Eastern Europe Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Therapeutic Drug Monitoring Market

  • 22.1. Russia Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Therapeutic Drug Monitoring Market

  • 23.1. North America Therapeutic Drug Monitoring Market Overview
  • 23.2. North America Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Therapeutic Drug Monitoring Market

  • 24.1. USA Therapeutic Drug Monitoring Market Overview
  • 24.2. USA Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Therapeutic Drug Monitoring Market

  • 25.1. Canada Therapeutic Drug Monitoring Market Overview
  • 25.2. Canada Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Therapeutic Drug Monitoring Market

  • 26.1. South America Therapeutic Drug Monitoring Market Overview
  • 26.2. South America Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Therapeutic Drug Monitoring Market

  • 27.1. Brazil Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Therapeutic Drug Monitoring Market

  • 28.1. Middle East Therapeutic Drug Monitoring Market Overview
  • 28.2. Middle East Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Therapeutic Drug Monitoring Market

  • 29.1. Africa Therapeutic Drug Monitoring Market Overview
  • 29.2. Africa Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Therapeutic Drug Monitoring Market Competitive Landscape And Company Profiles

  • 30.1. Therapeutic Drug Monitoring Market Competitive Landscape
  • 30.2. Therapeutic Drug Monitoring Market Company Profiles
    • 30.2.1. Abbott Laboratories Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. F. Hoffmann-La Roche AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Siemens Healthineers AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Thermo Fisher Scientific Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Sekisui Medical Co.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Therapeutic Drug Monitoring Market Competitive Benchmarking

32. Global Therapeutic Drug Monitoring Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Therapeutic Drug Monitoring Market

34. Therapeutic Drug Monitoring Market Future Outlook and Potential Analysis

  • 34.1 Therapeutic Drug Monitoring Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Therapeutic Drug Monitoring Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Therapeutic Drug Monitoring Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer